Suppr超能文献

慢性阻塞性肺疾病(COPD)患者全科医疗人群中肺量计测试的有效性。

Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD).

作者信息

Schermer T R, Jacobs J E, Chavannes N H, Hartman J, Folgering H T, Bottema B J, van Weel C

机构信息

Department of General Practice, University Medical Centre Nijmegen, The Netherlands.

出版信息

Thorax. 2003 Oct;58(10):861-6. doi: 10.1136/thorax.58.10.861.

Abstract

OBJECTIVE

To investigate the validity of spirometric tests performed in general practice.

METHOD

A repeated within subject comparison of spirometric tests with a "gold standard" (spirometric tests performed in a pulmonary function laboratory) was performed in 388 subjects with chronic obstructive pulmonary disease (COPD) from 61 general practices and four laboratories. General practitioners and practice assistants undertook a spirometry training programme. Within subject differences in forced expiratory volume in 1 second and forced vital capacity (DeltaFEV1 and DeltaFVC) between laboratory and general practice tests were measured (practice minus laboratory value). The proportion of tests with FEV1 reproducibility <5% or <200 ml served as a quality marker.

RESULTS

Mean DeltaFEV1 was 0.069 l (95% CI 0.054 to 0.084) and DeltaFVC 0.081 l (95% CI 0.053 to 0.109) in the first year evaluation, indicating consistently higher values for general practice measurements. Second year results were similar. Laboratory and general practice FEV1 values differed by up to 0.5 l, FVC values by up to 1.0 l. The proportion of non-reproducible tests was 16% for laboratory tests and 18% for general practice tests (p=0.302) in the first year, and 18% for both in the second year evaluation (p=1.000).

CONCLUSIONS

Relevant spirometric indices measured by trained general practice staff were marginally but statistically significantly higher than those measured in pulmonary function laboratories. Because of the limited agreement between laboratory and general practice values, use of these measurements interchangeably should probably be avoided. With sufficient training of practice staff the current practice of performing spirometric tests in the primary care setting seems justifiable.

摘要

目的

探讨在全科医疗中进行肺量计测试的有效性。

方法

对来自61家全科诊所和4个实验室的388例慢性阻塞性肺疾病(COPD)患者进行肺量计测试与“金标准”(在肺功能实验室进行的肺量计测试)的受试者内重复性比较。全科医生和诊所助理参加了肺量计培训项目。测量实验室测试与全科医疗测试之间一秒用力呼气容积和用力肺活量的受试者内差异(诊所测量值减去实验室测量值)。将一秒用力呼气容积重复性<5%或<200ml的测试比例作为质量指标。

结果

第一年评估时,平均一秒用力呼气容积差异为0.069L(95%CI0.054至0.084),用力肺活量差异为0.081L(95%CI0.053至0.109),表明全科医疗测量值始终较高。第二年结果相似。实验室和全科医疗的一秒用力呼气容积值相差可达0.5L,用力肺活量值相差可达1.0L。第一年实验室测试中不可重复测试的比例为16%,全科医疗测试为18%(p=0.302),第二年评估时两者均为18%(p=1.000)。

结论

经培训的全科医疗工作人员测量的相关肺量计指标略高于肺功能实验室测量的指标,但具有统计学意义。由于实验室和全科医疗测量值之间的一致性有限,可能应避免交替使用这些测量值。通过对诊所工作人员进行充分培训,在基层医疗环境中进行肺量计测试的现行做法似乎是合理的。

相似文献

5
Attaining a correct diagnosis of COPD in general practice.在全科医疗中实现慢性阻塞性肺疾病的准确诊断。
Respir Med. 2005 Apr;99(4):493-500. doi: 10.1016/j.rmed.2004.09.015. Epub 2004 Nov 11.
9
The objective evaluation of obstructive pulmonary diseases with spirometry.通过肺量计对阻塞性肺疾病进行客观评估。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 25;11:2009-15. doi: 10.2147/COPD.S113774. eCollection 2016.

引用本文的文献

9
Prediction of Pulmonary Function Parameters Based on a Combination Algorithm.基于组合算法的肺功能参数预测
Bioengineering (Basel). 2022 Mar 25;9(4):136. doi: 10.3390/bioengineering9040136.

本文引用的文献

1
Evaluation of diagnostic procedures.诊断程序的评估。
BMJ. 2002 Feb 23;324(7335):477-80. doi: 10.1136/bmj.324.7335.477.
9
Long-term performance of a hand held spirometer.手持式肺活量计的长期性能
Thorax. 1996 Oct;51(10):973-6. doi: 10.1136/thx.51.10.973.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验